Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,308 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Recruiting

Study of Out of Specification for Tisagenlecleucel

NCT04094311

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +25 more
Locations
  • Novartis Investigative Site Hamilton, Ontario, Canada
  • Novartis Investigative Site Ottawa, Ontario, Canada
  • Novartis Investigative Site Toronto, Ontario, Canada
  • Novartis Investigative Site Toronto, Ontario, Canada
View all 54 locations
View Trial Details
Recruiting

Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy

NCT07453095

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • AOU SS. Antonio e Biagio e Cesare Arrigo - SCDU Ematologia Alessandria, Italy
  • Policlinico S.Orsola-Malpighi - Istituto di Ematologia Seragnoli Bologna, Italy
  • ASST Spedali Civili - Ematologia Brescia, Italy
  • Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia Florence, Italy
View all 14 locations
View Trial Details
Recruiting

Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis

NCT05285891

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +8 more
Locations
  • Yale School of Medicine New Haven, Connecticut, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Northwestern University Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 13 locations
View Trial Details
Recruiting

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

NCT06292780

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • City of Hope Duarte, California, United States
  • Colorado Blood Cancer Institute/SCRI Denver, Colorado, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View all 20 locations
View Trial Details

Related conditions